TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 21, 2008 | $640,000 | Replaced |
| 1st Quarter - Amendment (this page) | Apr 29, 2008 | $640,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
President Bush FY 2008 Budget Request - $15.7 million dollars Generic Drug User Fees. Matters relating to FDA Office of Generic Drugs funding. H.R. 3161 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008 S. 1859 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2008
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| DAVID SANDERS | Patent & Trademark Office - Government Affairs |
Pharmacy PHA
S. 623 - Access to Life-Saving Medicine Act S. 438 - Fair Prescription Drug Competition Act H.R. 806 - Fair Prescription Drug Competition Act H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 5629 - The Pathway for Biologics Act H.R. 1038 - Access to Life-Saving Medicine Act S. 1505 - Affordable Biologics for Consumers Act S. 1695 - Biologics Price Competition and Innovation Act of 2007 H.R. 3610 - Food and Drug Import Safety Act of 2007
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| DAVID SANDERS | Patent & Trademark Office - Government Affairs |
Trade (domestic/foreign) TRD
Matters relating to Israeli data exclusivity. Matters relating to pharmaceutical provisions in free trade agreements.
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| DAVID SANDERS | Patent & Trademark Office - Government Affairs |
Copyright/Patent/Trademark CPT
H.R. 1432 - Preserve Access to Affordable Generics Act S. 316 - Preserve Access to Affordable Generics Act H.R. 1908 - Patent Reform Act of 2007 S. 1145 - Patent Reform Act of 2007 H.R. 1902 - Protecting Consumer Access to Generic Drugs Act
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| DAVID SANDERS | Patent & Trademark Office - Government Affairs |
Health Issues HCR
Proposals relating to prescription drug anti-counterfeiting efforts. H.R. 5839 - Safeguarding Americas Pharmaceuticals Act of 2008.
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| ROBERT FALB New | Rep. Visclosky, LA & LD (until 1991) |
| DAVID SANDERS | Patent & Trademark Office - Government Affairs |
Medicare/Medicaid MMM
S. 1951 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3700 - The Fair Medicaid Drug Payment Act of 2007 H.R. 3140 - Saving Our Community Pharmacies Act of 2007
Foreign entity interest: Teva Pharmaceutical Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issue(s) listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| DAVID SANDERS | Patent & Trademark Office - Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.